In patients 40 to 75 years of age with diabetes mellitus and LDL-C ≥70 mg/dL (≥1.8 mmol/L), start moderate-intensity statin therapy without calculating 10-year ASCVD risk.

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has conducted a Remote ...

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA) at Zydus' formulations manufacturing facility at Matoda in Gujarat for the Prior Approval Supplement (PAS) of ...

High-intensity statin therapy was classified as atorvastatin at doses of 40–80 mg or rosuvastatin at 20–40 mg, while moderate-intensity therapy included atorvastatin 10–20 mg or rosuvastatin 5–10 mg ...

In corroboration, evidence from a pilot study by Mroz et al. (2015) found that atorvastatin 40 mg daily for 12 weeks reduced serum CRP levels, sputum neutrophil count in lung biopsies, and the ...

Methods: 54 adults with atopic asthma were recruited to a double-blind randomised controlled crossover trial comparing the effect of oral atorvastatin 40 mg daily with that of a matched placebo on ...

Coadministration of multiple doses of 10 mg amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared with simvastatin alone. 29 However, coadministration of ...